News Headline Summary

EMA (European Medicines Agency) recommends Roche's (ROG) Perjeta for breast cancer

Reaction details:

- No immediate reaction to the news, last trade at CHF 186.40 (+0.27%)

Print 12:09, 14 Dec 2012 - SMI - Source: Newswires